| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 710,000 | 831,600 | 1,112,700 | 1,392,400 | | Cost of Revenue | 634,800 | 750,900 | 890,300 | 1,085,800 | | | Gross Profit | 75,200 | 80,700 | 222,400 | 306,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 64,400 | 80,800 | 59,000 | 74,300 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,800 | (100) | 163,400 | 232,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,700) | 500 | 7,000 | (2,600) | | Earnings Before Interest And Taxes | 1,100 | 400 | 162,800 | 229,700 | | Interest Expense | 1,100 | 100 | 700 | 1,700 | | Income Before Tax |
-
| 300 | 162,100 | 228,000 | | Income Tax Expense | 11,700 | (5,000) | 51,200 | 83,900 | | Minority Interest |
-
|
-
| (7,600) |
-
| | | | Net Income From Continuing Ops | (11,700) | 5,300 | 110,900 | 144,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,700) | 5,300 | 110,900 | 144,100 | | Preferred Stock And Other Adjustments | (1,700) | 600 |
-
|
-
| | | Net Income Applicable To Common Shares | ($13,400) | $5,900 | $110,900 | $144,100 |
|
2.03% Nasdaq 
Income Statement
